Rockwell Medical, Inc.
RMTI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $101 | $84 | $73 | $62 |
| % Growth | 21.4% | 14.8% | 17.6% | – |
| Cost of Goods Sold | $84 | $75 | $69 | $64 |
| Gross Profit | $17 | $9 | $4 | -$2 |
| % Margin | 17.2% | 10.4% | 5.6% | -3.9% |
| R&D Expenses | $0 | $1 | $3 | $7 |
| G&A Expenses | $14 | $12 | $16 | $15 |
| SG&A Expenses | $17 | $14 | $18 | $21 |
| Sales & Mktg Exp. | $3 | $2 | $2 | $6 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $17 | $15 | $21 | $28 |
| Operating Income | $1 | -$7 | -$17 | -$30 |
| % Margin | 0.6% | -8% | -23% | -49% |
| Other Income/Exp. Net | -$1 | -$2 | -$2 | -$2 |
| Pre-Tax Income | -$0 | -$8 | -$19 | -$33 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$8 | -$19 | -$33 |
| % Margin | -0.5% | -10.1% | -25.7% | -52.8% |
| EPS | -0.025 | -0.36 | -1.89 | -3.83 |
| % Growth | 93% | 81% | 50.7% | – |
| EPS Diluted | -0.025 | -0.36 | -1.89 | -3.83 |
| Weighted Avg Shares Out | 31 | 23 | 10 | 9 |
| Weighted Avg Shares Out Dil | 31 | 23 | 10 | 9 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $2 | $2 | $2 |
| Depreciation & Amortization | $2 | $1 | $1 | $3 |
| EBITDA | $3 | -$5 | -$16 | -$28 |
| % Margin | 2.9% | -5.6% | -22.2% | -44.9% |